Top Markets
Coin of the day
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
Rang in Aktien #12973
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Aktienkurs
$0.66137861
Marktkapitalisierung
$531.70M
Veränderung (1 Tag)
-2.45%
Veränderung (1 Jahr)
-42.12%
Land
CN
Handel Ocumension Therapeutics (1477)

Kategorie

Aktien-Split-Historie für Ocumension Therapeutics (1477)
Die Aktie Ocumension Therapeutics (Symbol: 1477) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 31, 2026 statt.
Eine 1477-Aktie, die vor dem Aug 31, 2026 gekauft wurde, entspricht heute 0 1477-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH